How does Praluent work?
Praluent (alirocumab) works by inactivating a protein in the liver called proprotein convertase subtilisin kexin 9 (PCSK9). It is classified as a PCSK9 inhibitor.
PCSK9 blocks the receptors that transport low density lipoprotein (LDL or "bad cholesterol) into the liver for metabolism (breakdown). Without these receptors, more LDL remains in the blood. So, by blocking PCSK9, more receptors are available to capture the bad LDL cholesterol for breakdown and removal from the blood. Lowering the LDL in the blood is better for the heart and can help to reduce the incidence of severe heart disease.
Praluent (alirocumab) is approved:
Praulent is given as a subcutaneous (under the skin) injection and comes as a pre-filled pen or pre-filled syringe. Your healthcare provider will teach you or your caregiver how to inject this medicine so you can use it at home.
Praluent is injected every 2 weeks OR every 4 weeks (monthly). Your healthcare provider will tell you your dose and schedule.
In studies, the most common side effects with Praluent were nasopharyngitis (common cold symptoms), injection site reactions and influenza (the flu).
This is not all the information you need to know about Praluent (alirocumab) for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full Praluent information here, and discuss this information and any questions you have with your doctor or other health care provider.
Related medical questions
- What are PCSK9 Inhibitors and how do they work?
- Praluent vs Repatha: What's the difference?
- How does Praluent work?
- What are PCSK9 Inhibitors and how do they work?
- Praluent vs Repatha: What's the difference?
- How does Praluent work?
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions